- Home
- ALOT vs HLVX Comparison
ALOT vs HLVX Comparison
Compare ALOT & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALOT
- HLVX
- Stock Information
- Founded
- ALOT 1969
- HLVX 2020
- Country
- ALOT United States
- HLVX United States
- Employees
- ALOT N/A
- HLVX N/A
- Industry
- ALOT Computer peripheral equipment
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- ALOT Technology
- HLVX Health Care
- Exchange
- ALOT Nasdaq
- HLVX Nasdaq
- Market Cap
- ALOT 114.8M
- HLVX 93.1M
- IPO Year
- ALOT N/A
- HLVX 2022
- Fundamental
- Price
- ALOT $12.62
- HLVX $1.90
- Analyst Decision
- ALOT
- HLVX Hold
- Analyst Count
- ALOT 0
- HLVX 5
- Target Price
- ALOT N/A
- HLVX $2.33
- AVG Volume (30 Days)
- ALOT 12.7K
- HLVX 311.4K
- Earning Date
- ALOT 12-12-2024
- HLVX 11-07-2024
- Dividend Yield
- ALOT N/A
- HLVX N/A
- EPS Growth
- ALOT 12.82
- HLVX N/A
- EPS
- ALOT 0.51
- HLVX N/A
- Revenue
- ALOT $153,515,000.00
- HLVX N/A
- Revenue This Year
- ALOT N/A
- HLVX N/A
- Revenue Next Year
- ALOT N/A
- HLVX N/A
- P/E Ratio
- ALOT $23.82
- HLVX N/A
- Revenue Growth
- ALOT 3.48
- HLVX N/A
- 52 Week Low
- ALOT $11.00
- HLVX $1.55
- 52 Week High
- ALOT $18.25
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- ALOT 48.69
- HLVX 42.75
- Support Level
- ALOT $12.00
- HLVX $1.87
- Resistance Level
- ALOT $13.38
- HLVX $2.15
- Average True Range (ATR)
- ALOT 0.53
- HLVX 0.09
- MACD
- ALOT 0.11
- HLVX -0.02
- Stochastic Oscillator
- ALOT 68.07
- HLVX 10.71
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.